Supreme Pharmaceuticals Inc. ("Supreme") (CSE:SL; OTCBB:SPRWF) is a publicly traded marijuana company based in Toronto, Canada. Supreme’s wholly owned subsidiary, 7ACRES/AMMcan, was issued a Canadian federal license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations on March 11, 2016 (now the ACMPR). Supreme is one of the newest marijuana Licensed Producers (LP) in Canada’s marijuana market, and is well positioned with its high capacity innovative hybrid greenhouse and B2B focused business model.